Clinical Trial Update: CommunityRx-Cardiovascular Disease [NA]

View source ↗

Summary

This clinical trial update indicates that the CommunityRx study for cardiovascular disease, sponsored by the University of North Carolina, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Cardiovascular Diseases, Self Efficacy | NA | Status: COMPLETED